HBK Sorce Advisory LLC Makes New Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

HBK Sorce Advisory LLC acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 431 shares of the biotechnology company’s stock, valued at approximately $256,000.

A number of other hedge funds also recently added to or reduced their stakes in AXON. Atria Investments Inc lifted its position in Axon Enterprise by 31.4% during the 3rd quarter. Atria Investments Inc now owns 3,901 shares of the biotechnology company’s stock worth $1,559,000 after acquiring an additional 933 shares during the period. Los Angeles Capital Management LLC purchased a new stake in shares of Axon Enterprise in the third quarter valued at approximately $709,000. Apollon Wealth Management LLC boosted its stake in shares of Axon Enterprise by 11.3% in the third quarter. Apollon Wealth Management LLC now owns 1,304 shares of the biotechnology company’s stock valued at $521,000 after buying an additional 132 shares in the last quarter. GSA Capital Partners LLP boosted its stake in shares of Axon Enterprise by 61.2% in the third quarter. GSA Capital Partners LLP now owns 1,736 shares of the biotechnology company’s stock valued at $694,000 after buying an additional 659 shares in the last quarter. Finally, KBC Group NV boosted its stake in shares of Axon Enterprise by 80.6% in the third quarter. KBC Group NV now owns 12,397 shares of the biotechnology company’s stock valued at $4,954,000 after buying an additional 5,532 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of analyst reports. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Needham & Company LLC restated a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Barclays restated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 1,370 shares of the company’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $639.14, for a total value of $875,621.80. Following the completion of the transaction, the insider now directly owns 125,950 shares in the company, valued at approximately $80,499,683. This represents a 1.08 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,146 shares of company stock valued at $3,262,847 over the last three months. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $556.26 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The stock has a market cap of $42.62 billion, a price-to-earnings ratio of 143.74, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The business has a fifty day moving average of $593.42 and a 200-day moving average of $535.46. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.